POCT BNP

A brain natriuretic peptide (BNP) test measures the amount of the BNP hormone in the blood. BNP is used to help detect, diagnose and evaluate the severity of heart failure and monitor progress with treatment. The PoCT BNP programme is administered as part of the Weqas BNP EQA programme accommodating both Laboratory and Point of Care testing.

This programme has been designed to simulate the composition of patient samples in order to correctly reflect the expected performance with patient samples. For PoCT plasma BNP, three human plasma samples at an appropriate physiological range are distributed every 2 months.

Frequency: Bimonthly

Samples per set: 3 x 0.5mL

BNP Programme
AnalyteApprox. Range Covered
BNP 3220 - 3000pg/mL
BNP Triage20 - 1000 pg/mL
NT-pro BNP20 - 4000pg/mL

Related Documents

 

Browse all POCT EQA Programmes

Accreditation

UKAS Proficiency Testing 4301UKAS Calibration 4301


Events

  1. AACC Annual Conference – Chicago

    31st July - 2nd August
  2. Harrogate EQA Workshop

    20th September